Retatrutide 10mg is an investigational triple-agonist peptide (GIP, GLP-1, and glucagon receptor) designed for once-weekly subcutaneous injection to treat severe obesity, manage weight, and improve metabolic health, including type 2 diabetes. It has shown significant weight reduction (up to 24%–29%) in clinical trials by reducing appetite and increasing calorie